Collegium Pharmaceutical Financial Overview
Collegium Pharmaceutical's market cap is currently $1.54B. The company's EPS TTM is $2.25; its P/E ratio is 30.44; Collegium Pharmaceutical is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $2.15. See an overview of income statement, balance sheet, and cash flow financials.
